Kurma Partners
Status
ACTIVE
Global HQ
Paris, France
Countries of investment
- France
- Germany
Investment stages
- Seed
Industries
- Fintech
- AI
- Health Tech
- Blockchain
About
Kurma Partners is a key European venture capital group specializing in healthcare and biotechnology, with a strong focus on transforming scientific discoveries into cutting-edge medical solutions for severe diseases.
Kurma Partners is a key European venture capital group specializing in healthcare and biotechnology, with a strong focus on transforming scientific discoveries into cutting-edge medical solutions for severe diseases.
Investment Thesis
Kurma Partners is a major player in the funding of healthcare and biotechnology in Europe, investing at various stages of maturity, from company creation to capital expansion.
Manager's Experience
With extensive experience in private equity, the fund manager has executed over 50 transactions primarily in the technology and healthcare sectors across Europe and North America. Emphasizing a thematic investment approach, their portfolio reflects a strong focus on innovation-driven companies at growth and expansion stages. Notable exits include several successful IPOs and strategic sales, showcasing a data-driven methodology that balances operational expertise with market insights. Their strategic style prioritizes operator-first investments, ensuring alignment with management teams to drive value creation.
Team
Thierry Laugel - Founder & Managing Partner
Rémi Droller - Managing Director
Daniel Parera - Partner
Portfolio
Amolyt Pharma
ImCheck Therapeutics
Corlieve Therapeutics
Emergence Therapeutics
SciRhom
Memo Therapeutics
Avidicure
Synendos Therapeutics
VICO Therapeutics
Damae Medical
Alveus Therapeutics
LaigoBio
MedinCell
IO Biotech
Pharvaris
Adocia
ABM Pharmareva
Corteria
MedLumics
Basis